 Sanofi SA NASDAQ:SNY Q3 2022 Results Conference Call October 28, 2022 8:30 AM ET Company Participants Eva Schaefer-Jansen - Head, IR Paul Hudson - CEO Bill Sibold - EVP, Specialty Care; President, North America Thomas Triomphe - EVP, Vaccines Olivier Charmeil - EVP, General Medicines Julie Van Ongevalle - EVP, Consumer Healthcare Jean-Baptiste de Chatillon - CFO John Reed - EVP Global Head, Research Development Roy Papatheodorou - EVP, General Counsel Head of Legal, Ethics Business Brendan OCallaghan - EVP, Global Industrial Affairs Conference Call Participants Graham Parry - Bank of America Securities Wimal Kapadia - Bernstein Richard Parkes - Exane BPN Emily Field - Barclays Peter Welford - Jefferies David Risinger - SVB Leerink Jo Walton - Credit Suisse Peter Verdult - Citigroup Luisa Hector - Berenberg Richard Vosser - JPMorgan Keyur Parekh - Goldman Sachs Eva Schaefer-Jansen Good morning, good afternoon, and good evening to everyone. Thank you for joining us to review Sanofis 2022 third quarter results, followed by a QA session. 